James C. Hamilton, Insider at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 46,141 shares at $62.64 ($3.0M) on 2022-01-05, disclosed to the SEC on 2022-01-06.
Open-market sale of $3.0M ARWR by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.89 | 9,955 | $646K | 21.7% |
| 2 | $64.89 | 9,955 | $646K | 21.7% |
| 3 | $65.59 | 7,469 | $490K | 16.4% |
| 4 | $65.59 | 7,469 | $490K | 16.4% |
| 5 | $67.39 | 802 | $54K | 1.8% |
| 6 | $67.39 | 802 |
| $54K |
| 1.8% |
| 7 | $68.12 | 649 | $44K | 1.5% |
| 8 | $69.38 | 500 | $35K | 1.2% |
| 9 | $60.51 | 2,290 | $139K | 4.6% |
| 10 | $60.51 | 2,290 | $139K | 4.6% |
| 11 | $61.84 | 2,100 | $130K | 4.4% |
| 12 | $62.64 | 1,100 | $69K | 2.3% |
| 13 | $63.68 | 700 | $45K | 1.5% |
| 14 | $64.35 | 60 | $4K | 0.1% |
| Total | $64.65 avg | 46,141 | $3.0M | 100% |
| Filing → |
| ARWR | SELL | 2026-01-05 | $2.5M | — | Filing → |
| ARWR | SELL | 2025-10-03 | $700K | — | Filing → |
| ARWR | SELL | 2025-09-16 | $450K | — | Filing → |